|
Australia & New Zealand Pharmaceuticals News. Service for global professionals. Constantly updated news and information about Australia & New Zealand Pharmaceuticals.
Latest Australia & New Zealand Pharmaceuticals News
- Ireland dip 5 places in investment table 23 Nov 2009 12:32 GMT
... green technologies, a strong highly attractive Medical Device/Pharmaceutical Industry as well as a drop in valuations ... the road to economic recovery. For example, Australia would not have a strong history as ...
- German Pharmaceutical Wholesaler Fiebig Goes Live With IBS Pharma 23 Nov 2009 10:31 GMT
... product. Sydney, NSW, November 20, 2009 -- Pharmaceutical wholesaler Leopold Fiebig has now fully implemented ... fully implemented the IBS Pharma for its industry-specific, highly customized financial accounting processes which, as ... 75 Fiona Chong, Marketing Communication Specialist, IBS Australia Phone: 1300 882 467 About IBS IBS ...
- iSOFT Business Solutions (ASX:ISF) Wins New Deals Worth A$10 Million 23 Nov 2009 02:40 GMT
... Nov 23, 2009 (ABN Newswire) - iSOFT Business Solutions (ASX:ISF) Australia's largest listed health information technology company today ... to manage the ordering and supply of non-pharmaceutical goods to 600 National Health Services trusts ...
- Colonial buys 10.8m Australian Pharmaceuticals shares 23 Nov 2009 11:15 GMT
... Colonial First State Investments bought 10,813,076 Australian Pharmaceuticals Industries shares for $7,488,749 from August 19 to November 13, 2009, increasing from 8,434,106 ...
- Nereus Pharmaceuticals Presents Positive Interim Data from the ADVANCE Study, a Randomized Phase 2 Clinical Trial of Plinabulin (NPI-2358) in Non-Small Cell Lung Cancer at the 2009 EORTC-NCI-AACR Conf 23 Nov 2009 13:30 GMT
... SAN DIEGO--(BUSINESS WIRE)-- Nereus Pharmaceuticals, Inc., a pioneer in drug discovery from ... at clinical trial sites in the U.S., Australia, India, and South America, of which 110 ...
- Nereus Pharmaceuticals Presents Positive Interim Data from the ADVANCE Study, a Randomized Phase 2 Clinical Trial of Plinabulin (NPI-2358) in Non-Small Cell Lung Cancer at the 2009 EORTC-NCI-AACR Conference 23 Nov 2009 13:30 GMT
... Nereus Pharmaceuticals Presents Positive Interim Data from the ADVANCE ... EORTC-NCI-AACR Conference SAN DIEGO, Nov 23, 2009 (BUSINESS WIRE) -- Nereus Pharmaceuticals, Inc., a pioneer ... at clinical trial sites in the U.S., Australia, India, and South America, of which 110 ...
- Provectus Pharmaceuticals announces Phase 1 interim study data of PV-10 for metastatic melanoma 23 Nov 2009 13:26 GMT
... Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology ... PVCT), a development-stage oncology and dermatology biopharmaceutical company, announced today that initial one year overall ... of Sydney, Director of the Melanoma Institute Australia, and Lead Investigator of the Phase 2 ...
- 200 jobs to go as McCain factory shuts 23 Nov 2009 07:41 GMT
... Tasmanian factory in favour of expanding its New Zealand base. [keywords] => McCain, Tasmania, Smithton, factory, ... northwest, are expected to turn to growing pharmaceutical poppy crops instead. McCain says it will ... longer financially viable. Experts say the strong Australian dollar and the relatively high costs of ...
- 200 jobs to go in factory shutdown 23 Nov 2009 05:35 GMT
... Tasmanian factory in favour of expanding its New Zealand base will cost up to 200 jobs ... Tasmania's northwest, are expected to turn to pharmaceutical poppy crops. McCain will keep its potato ... longer financially viable. Experts say the strong Australian dollar and the relatively high costs of ...
- McCain gives Tassie vegies the chop 23 Nov 2009 06:12 GMT
... VEGETABLES processor McCain's decision to close its Tasmanian ... Tasmanian factory in favour of expanding its New Zealand base will cost up to 200 jobs ... Tasmania's northwest, are expected to turn to pharmaceutical poppy crops. McCain will keep its potato ...
- CDC Software Reports $0.33 in Non-GAAP Earnings Per Share for the Third Quarter of 2009 and Operating Cash Flow of $19.2 Million, up over 200 Percent Year over Year 23 Nov 2009 11:30 GMT
... seen increased channel sales activity in India, Australia, Mexico and in China The company believes ... Harris County), Natures Way, Rothschild, Shanghai Roche Pharmaceuticals Ltd., Sudzucker, The9 Computer Technology Consulting Co., ... penetrate further in the Tier 1 automotive industry." WKD Solutions and Activplant were completed during ...
- Morality: Right to health care (31 Comments) 23 Nov 2009 03:54 GMT
... full blown government takeover of the healthcare industry if it reduces how much I pay ... than half of what it cost us. Australia has had universal care since 1984 and ... tough price controls on all providers and pharmaceutical firms. They deliver better care and save ...
- Morality: Right to health care (27 Comments) 23 Nov 2009 06:15 GMT
... full blown government takeover of the healthcare industry if it reduces how much I pay ... than half of what it cost us. Australia has had universal care since 1984 and ... tough price controls on all providers and pharmaceutical firms. They deliver better care and save ...
- Morality: Right to health care (19 Comments) 23 Nov 2009 07:44 GMT
... full blown government takeover of the healthcare industry if it reduces how much I pay ... than half of what it cost us. Australia has had universal care since 1984 and ... tough price controls on all providers and pharmaceutical firms. They deliver better care and save ...
- Labopharm to present at Dundee Emerging Growth Summit 23 Nov 2009 03:12 GMT
... President & Chief Executive Officer of the Company, will present at the Dundee Emerging Growth ... the U.S., Canada, major European markets and Australia. The Company's second product, a novel formulation ... is to become an integrated, international, specialty pharmaceutical company with the capability to internally develop ...
Powered by 
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>>
| |
|